Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer
Authors:
Article info
2023-12-05
2024-05-11
2024-09-05
None - None
Keywords
- factor
- oligonucleotides
- splice
- Alternative
- switch
- splicing;
- splicing
- mutations;
- factors;
- spliseosome;
Abstract
mRNA splicing constitutes a crucial biological phenomenon characterized by the excision of introns from pre-mRNA, followed by the synthesis of mature mRNA through the concatenation of the remaining exons. In eukaryotic cells, the process of alternative splicing introduces a diverse array of exon combinations, thereby exerting a significant influence on the generation of protein diversity. The occurrence of recurrent mutations during RNA splicing or within the core components of the spliceosome is implicated in the etiology and progression of diverse diseases, prominently including cancer. This review article scrutinizes the aberrations in RNA splicing linked to cancer and explores therapeutic endeavors directed at addressing mutations in RNA splicing.
Rabaya, D., & Adwan, G. (2025). Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer. An-Najah University Journal for Research - A (Natural Sciences), 39(1). https://doi.org/10.35552/anujr.a.39.1.2254
[1]D. Rabaya and G. Adwan, “Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer,” An-Najah University Journal for Research - A (Natural Sciences), vol. 39, no. 1, Feb. 2025, doi: 10.35552/anujr.a.39.1.2254.
Rabaya, Doaa, and Ghaleb Adwan. “Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer.” An-Najah University Journal for Research - A (Natural Sciences), vol. 39, no. 1, Feb. 2025. Crossref, https://doi.org/10.35552/anujr.a.39.1.2254.
1.Rabaya D, Adwan G. Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer. An-Najah University Journal for Research - A (Natural Sciences) [Internet]. 2025 Feb;39(1). Available from: http://dx.doi.org/10.35552/anujr.a.39.1.2254
Rabaya, Doaa, and Ghaleb Adwan. “Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer.” An-Najah University Journal for Research - A (Natural Sciences) 39, no. 1 (February 2025). https://doi.org/10.35552/anujr.a.39.1.2254.
Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer
المؤلفون:
معلومات المقال
2023-12-05
2024-05-11
2024-09-05
None - None
الكلمات الإفتتاحية
- factor
- oligonucleotides
- splice
- Alternative
- switch
- splicing;
- splicing
- mutations;
- factors;
- spliseosome;
الملخص
mRNA splicing constitutes a crucial biological phenomenon characterized by the excision of introns from pre-mRNA, followed by the synthesis of mature mRNA through the concatenation of the remaining exons. In eukaryotic cells, the process of alternative splicing introduces a diverse array of exon combinations, thereby exerting a significant influence on the generation of protein diversity. The occurrence of recurrent mutations during RNA splicing or within the core components of the spliceosome is implicated in the etiology and progression of diverse diseases, prominently including cancer. This review article scrutinizes the aberrations in RNA splicing linked to cancer and explores therapeutic endeavors directed at addressing mutations in RNA splicing.
Rabaya, D., & Adwan, G. (2025). Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer. An-Najah University Journal for Research - A (Natural Sciences), 39(1). https://doi.org/10.35552/anujr.a.39.1.2254
[1]D. Rabaya and G. Adwan, “Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer,” An-Najah University Journal for Research - A (Natural Sciences), vol. 39, no. 1, Feb. 2025, doi: 10.35552/anujr.a.39.1.2254.
Rabaya, Doaa, and Ghaleb Adwan. “Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer.” An-Najah University Journal for Research - A (Natural Sciences), vol. 39, no. 1, Feb. 2025. Crossref, https://doi.org/10.35552/anujr.a.39.1.2254.
1.Rabaya D, Adwan G. Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer. An-Najah University Journal for Research - A (Natural Sciences) [Internet]. 2025 Feb;39(1). Available from: http://dx.doi.org/10.35552/anujr.a.39.1.2254
Rabaya, Doaa, and Ghaleb Adwan. “Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer.” An-Najah University Journal for Research - A (Natural Sciences) 39, no. 1 (February 2025). https://doi.org/10.35552/anujr.a.39.1.2254.
An-Najah National University
Nablus, Palestine
Nablus, Palestine
- P.O. Box
- 7, 707
- Fax
- (970)(9)2345982
- Tel.
- (970)(9)2345560
- (970)(9)2345113/5/6/7-Ext. 2628
- [email protected]
- EIC
- Prof. Waleed Sweileh
An-Najah University Journal for Research - A (Natural Sciences) by An-Najah University, Nablus, Palestine is licensed under CC BY-NC 4.0